Skip to main content


      Making AI Ethics a Shared Language for Trusted and Equitable AI for Health

      As AI capabilities advance rapidly, safety evaluation, regulation, and institutional governance are struggling to keep pace. Slowing the pace of AI development may buy time, but it does not answer the more fundamental question: how should that time be used to ensure that AI is developed and deployed responsibly? Recent global discussions highlight a shift from focusing solely on AI safety toward broader human-development concerns, including preserving human capabilities, reflecting diverse knowledge and cultural contexts, maintaining human accountability, enabling responsible data use, and ensuring that AI systems are verifiable and inclusive. 

      These challenges are particularly significant for AI for Health in low- and middle-income countries (LMICs). Models trained predominantly on data from higher-income settings may not perform reliably across different epidemiological and population contexts. At the same time, digital determinants of health, including connectivity, interoperable health information systems and digital literacy, influence who can benefit from AI. Limited capacity for local validation and post-deployment monitoring may further widen the gap between ethical principles and their practical implementation. 

      To bridge this principles-to-practice gap, the report proposes a shared risk-check framework aligned with the AI for Health lifecycle. Across ideation and R&D, data procurement and model training, clinical validation and regulatory clearance, and deployment and post-market surveillance would apply a common set of questions covering issues such as data representativeness, local validity, human oversight, accountability, model drift, accessibility, and health equity. 

      The objective is not to create another compliance checklist, but to establish a common operational language that enables developers, policymakers, regulators, procurers, funders, and other stakeholders to identify and address risks consistently. In this way, AI ethics can become an enabler of trusted, scalable and equitable AI for Health, rather than a brake on innovation, while keeping the needs of the most vulnerable populations at the center of technological progress. 


      Author

      KPMG AZSA LLC
      Director - Healthcare & Well-being (HC&WB)
      Michikazu Koshiba

      whx-dubai-2026-rapid-brief

      AI for Health in Global Health

      Pacing Is Not Enough: Making AI Ethics the Shared Language for AI for Health Innovation


      This report is published as a record of participation in the 79th World Health Assembly (WHA79), held in Geneva in May 2026. We invite you to review our analysis of the emerging Global Health Architecture shaped by the interplay of Planetary Health, Sustainable Health Finance, and AI for Health.

      This rapid brief summarizes key insights and observations from WHX, with a particular focus on the depth and diversity of its agenda, including life‑course‑oriented Women’s Health, Middle East–Africa (MEA) market strategies, and the evolving regulatory and manufacturing landscape shaping emerging healthcare markets.